CIK 0001842939 · <br>Emerging growth company
Longevity Health Holdings, Inc.
Sign in to watch- Tickers
- XAGE XAGEW
- Exchange
- OTC
- Industry
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 861645738
- Phone
- 412-894-8248
- Business address
- 2403 SIDNEY STREET, SUITE 300, PITTSBURGH, PA, 15203
- Former names
- Carmell Corp, ALPHA HEALTHCARE ACQUISITION CORP III
Securities
- XAGE Common stock OTC
- XAGEW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-14 | Hart James C Chief Medical Officer | Grant or award · Stock Option (right to buy) | +5,318 | 5,318 | ||
| 2023-07-14 | Hart James C Chief Medical Officer | Grant or award · Stock Option (right to buy) | +9,161 | 9,161 | ||
| 2023-07-14 | Hart James C Chief Medical Officer | Grant or award · Stock Option (right to buy) | +109,937 | 109,937 | ||
| 2023-07-14 | Hart James C Chief Medical Officer | Grant or award · Stock Option (right to buy) | +12,309 | 12,309 | ||
| 2023-07-14 | Hart James C Chief Medical Officer | Grant or award · Stock Option (right to buy) | +12,309 | 12,309 | ||
| 2023-07-14 | Hubbell Randolph W CEO & President | Grant or award · Stock Option (right to buy) | +217,175 | 217,175 | ||
| 2023-07-14 | Hubbell Randolph W CEO & President | Grant or award · Stock Option (right to buy) | +37,642 | 37,642 | ||
| 2023-07-14 | Hubbell Randolph W CEO & President | Grant or award · Stock Option (right to buy) | +480,110 | 480,110 | ||
| 2023-07-14 | Anderson David W Director | Grant or award · Stock Option (right to buy) | +16,285 | 16,285 | ||
| 2023-07-14 | Anderson David W Director | Grant or award · Stock Option (right to buy) | +19,910 | 19,910 | ||
| 2023-07-14 | Anderson David W Director | Grant or award · Stock Option (right to buy) | +8,509 | 8,509 | ||
| 2023-07-14 | Anderson David W Director | Grant or award · Stock Option (right to buy) | +32,173 | 32,173 | ||
| 2023-07-14 | Bariahtaris Steven Director | Grant or award · Stock Option (right to buy) | +76,878 | 76,878 | ||
| 2023-07-14 | Vargo Janet VP Clinical Services | Grant or award | +27,030 | 27,030 | ||
| 2023-07-14 | Vargo Janet VP Clinical Services | Grant or award · Stock Options (right to buy) | +1,045 | 1,045 | ||
| 2023-07-14 | Vargo Janet VP Clinical Services | Grant or award · Stock Options (right to buy) | +16,629 | 16,629 | ||
| 2023-07-14 | Vargo Janet VP Clinical Services | Grant or award · Stock Options (right to buy) | +119,098 | 119,098 | ||
| 2023-07-14 | Vargo Janet VP Clinical Services | Grant or award · Stock Options (right to buy) | +12,309 | 12,309 | ||
| 2023-01-02 | Shukla Rajiv Chairman and CEO | Grant or award | +14,347 | 48,526 | ||
| 2021-09-23 | Upton Richard A Director | Other acquisition | +0 | 54,445 |
Page 9 of 10 · 195 trades